Correlation Between MACOM Technology and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MACOM Technology and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MACOM Technology and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MACOM Technology Solutions and CERo Therapeutics Holdings, you can compare the effects of market volatilities on MACOM Technology and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MACOM Technology with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MACOM Technology and CERo Therapeutics.

Diversification Opportunities for MACOM Technology and CERo Therapeutics

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between MACOM and CERo is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding MACOM Technology Solutions and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and MACOM Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MACOM Technology Solutions are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of MACOM Technology i.e., MACOM Technology and CERo Therapeutics go up and down completely randomly.

Pair Corralation between MACOM Technology and CERo Therapeutics

Given the investment horizon of 90 days MACOM Technology is expected to generate 9.34 times less return on investment than CERo Therapeutics. But when comparing it to its historical volatility, MACOM Technology Solutions is 8.38 times less risky than CERo Therapeutics. It trades about 0.27 of its potential returns per unit of risk. CERo Therapeutics Holdings is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest  0.93  in CERo Therapeutics Holdings on October 29, 2024 and sell it today you would earn a total of  1.02  from holding CERo Therapeutics Holdings or generate 109.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MACOM Technology Solutions  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
MACOM Technology Sol 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MACOM Technology Solutions are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, MACOM Technology demonstrated solid returns over the last few months and may actually be approaching a breakup point.
CERo Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

MACOM Technology and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MACOM Technology and CERo Therapeutics

The main advantage of trading using opposite MACOM Technology and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MACOM Technology position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind MACOM Technology Solutions and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios